1. Home
  2. Labeler Index
  3. Ionis Pharmaceuticals, Inc.
  4. 71860-101
  5. NDC Package Code: 71860-101-01 Tryngolza

NDC Package 71860-101-01 Tryngolza

Olezarsen Sodium Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71860-101-01
Package Description:
1 SYRINGE, GLASS in 1 CARTON / .8 mL in 1 SYRINGE, GLASS
Product Code:
71860-101
Proprietary Name:
Tryngolza
Non-Proprietary Name:
Olezarsen Sodium
Substance Name:
Olezarsen Sodium
Usage Information:
TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
11-Digit NDC Billing Format:
71860010101
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Ionis Pharmaceuticals, Inc.
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
OLEZARSEN SODIUM 80 mg/.8mL
Sample Package:
No
FDA Application Number:
NDA218614
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
12-19-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71860-101-01?

The NDC Packaged Code 71860-101-01 is assigned to a package of 1 syringe, glass in 1 carton / .8 ml in 1 syringe, glass of Tryngolza, a human prescription drug labeled by Ionis Pharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 71860-101 included in the NDC Directory?

Yes, Tryngolza with product code 71860-101 is active and included in the NDC Directory. The product was first marketed by Ionis Pharmaceuticals, Inc. on December 19, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 71860-101-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 71860-101-01?

The 11-digit format is 71860010101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-271860-101-015-4-271860-0101-01